Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.46 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.44 |
| ▸ | TUBB | P07437 | 2/20 | 0.44 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.44 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.44 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.44 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.44 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.44 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.44 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.44 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.44 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.44 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4186794 | 0.90 | KDM4E (0.50) | ALDH1A1GLAKDM4EMAPTLMNA | |
| SCHEMBL27627375 | 0.85 | NCEH1 (0.49) | BACE1ALDH1A1F2GLAHPGD | |
| SCHEMBL2168670 | 0.84 | AKR1C3 (0.46) | ALDH1A1HPGDKDM4EMTNR1ACYP1A2 | |
| SCHEMBL4194130 | 0.83 | CA12 (0.52) | ALDH1A1MTNR1AMTNR1BTUBB4ATUBB | |
| SCHEMBL30503987 | 0.83 | CA12 (0.52) | ALDH1A1MTNR1AMTNR1BTUBB4ATUBB | |
| SCHEMBL7099992 | 0.81 | MTNR1A (0.52) | BACE1ALDH1A1F2GLAHPGD | |
| SCHEMBL8605610 | 0.80 | BACE1 (0.56) | BACE1ALDH1A1F2GLAHPGD | |
| SCHEMBL9506861 | 0.80 | TUBB4A (0.50) | BACE1ALDH1A1F2GLAHPGD | |
| SCHEMBL20414572 | 0.80 | CFD (0.51) | ALDH1A1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL253760 | 0.79 | GLA (0.65) | BACE1ALDH1A1F2GLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8709819-B2 | Preparation and its use of derivatization reagent for detecting L-carnitine or D-carnitine | GU SHUHUA (CN) | 2014-04-29 | — | — | US | disclosed |
| EP-2348315-B1 | PREPARATION AND ITS USE OF DERIVATISATION REAGENT FOR DETECTING L-CARNITINE OR D-CARNITINE | CHANGZHOU MULTIPLE DIMENSION INST OF INDUSTRY TECHNOLOGY CO LTD (CN) | 2013-12-18 | — | — | EP | disclosed |
| US-20110281293-A1 | PREPARATION AND ITS USE OF DERIVATIZATION REAGENT FOR DETECTING L-CARNITINE OR D-CARNITINE | GU SHUHUA (CN) | 2011-11-17 | — | — | US | disclosed |
| EP-2348315-A1 | PREPARATION AND ITS USE OF DERIVATISATION REAGENT FOR DETECTING L-CARNITINE OR D-CARNITINE | Changzhou Multiple Dimension Institute Of Industry Technology Co., Ltd. (CN) | 2011-07-27 | — | — | EP | disclosed |
| US-4496589-A | TOPICAL | AUSONIA FARMACEUTICI S.R.L. (IT) | 1985-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110281293-A1 | PREPARATION AND ITS USE OF DERIVATIZATION REAGENT FOR DETECTING L-CARNITINE OR D-CARNITINE | CRAT, CPT1B, SLC25A20 | BACE1 1137/4885ALDH1A1 288/4885F2 802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.